CurrentEndo
Get Weekly

Topic · page 19 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 721–760 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE Study

    Secondary analysis

  2. Diabetes Obes Metab

    Identifying Predictors of Early Treatment Intensification in Individuals With Type 2 Diabetes Treated With GLP ‐1 Receptor Agonists: A Machine Learning–Based Analysis of a Large Real World Cohort

    Cohort study

  3. Diabetes Obes Metab

    Reframing Diabetes Mellitus as a Multiaxial Disease Continuum: The Diabetes Severity Classification ( DSC ) Framework

    Research article

  4. Horm Res Paediatr

    Prediabetes and Type 2 Diabetes in Youth following Premature Adrenarche

    Cohort study

  5. Diabetologia

    Mitochondrial cristae density is increased following high-intensity interval training in men with type 2 diabetes

    Randomized controlled trial

  6. Diabetes Obes Metab

    Circulating Rhythmic Metabolites and Causal Risk of Type 2 Diabetes in Adults in the Canadian Longitudinal Study on Aging

    Cohort study

  7. Diabetes Obes Metab

    GLP ‐1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation

    Cohort study

  8. Diabetes Obes Metab

    Type 2 diabetes subphenotypes are associated with differential outcomes after metabolic and bariatric surgery: An international multicentre retrospective cohort study

    Cohort study

  9. Diabetes Res Clin Pract

    Cardiovascular outcomes of GLP-1RA vs SGLT2i in MASLD and type 2 diabetes: real-world evidence

    Cohort study

  10. J Diabetes Sci Technol

    Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report

    Guideline or statement

  11. BMJ Open Diabetes Res Care

    Cardiovascular autonomic dysfunction is linked with arterial stiffness across glucose metabolism: the Maastricht study

    Cross-sectional study

  12. Cardiovasc Diabetol

    Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus

    Meta-analysis

  13. Cardiovasc Diabetol

    Prognostic stratification of cardiovascular risk and cardiac remodeling in prediabetes: a multimodal analysis comparing ADA and WHO/IEC diagnostic criteria

    Cohort study

  14. Diabetologia

    Systematic analysis of loss-of-function variants across MODY genes demonstrates gene-specific effects and expands the spectrum of INS variants causing MODY

    Case-control study

  15. BMJ Open Diabetes Res Care

    Association of weekday sleep duration and estimated glucose disposal rate: the role of weekend catch-up sleep

    Cross-sectional study

  16. J Diabetes Sci Technol

    Differences in Continuous Glucose Monitoring Metrics Between Prediabetes and Normoglycemia: A Systematic Review and Meta-Analysis

    Meta-analysis

  17. J Diabetes Sci Technol

    Red Blood Cell Metabolomic Signatures in β-Thalassemia Heterozygotes With Elevated HbA 1c : Implications for Biomarkers and Personalized Medicine

    Cross-sectional study

  18. J Diabetes Sci Technol

    Associations Between Screen Exposure, Multidimensional Sleep Indicators, and Type 2 Diabetes: A Cross-sectional Study Using US National Survey Data

    Cross-sectional study

  19. Cardiovasc Diabetol

    Prognostic stratification with composite insulin resistance–inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses

    Cohort study

  20. JAMA Netw Open

    Adherence to Healthy Lifestyle and Risk of Cardiometabolic Diseases in Individuals With Hypertension

    Cohort study

  21. JAMA Netw Open

    GLP-1 Receptor Agonists and Noncardiometabolic Outcomes: An Umbrella Review of Meta-Analyses

    Meta-analysis

  22. JAMA Intern Med

    SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes

    Cohort study

  23. J Diabetes Sci Technol

    Discordance Between HbA1c and Glucose Management Indicator in People With Type 2 Diabetes Treated With SGLT2 Inhibitors

    Cohort study

  24. Cardiovasc Diabetol

    Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis

    Meta-analysis

  25. J Clin Endocrinol Metab

    Association of genetic risk and physical activity with incident type 2 diabetes

    Cohort study

  26. Diabetes Obes Metab

    Dose‐Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting

    Meta-analysis

  27. Diabetes Obes Metab

    Evaluating the Impact of Putative Metformin Targets on Cancer Outcomes: A Drug‐Target Mendelian Randomization Study

    Research article

  28. Diabetes Obes Metab

    Impact of early and tight HbA1c control on the risk of long‐term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register

    Cohort study

  29. J Diabetes Sci Technol

    Training and Evaluation of a Breath-Based Glucose Estimation Algorithm in People With Type 2 Diabetes: The BOYDSense-GM Study

    Diagnostic or prognostic study

  30. Diabetes Res Clin Pract

    The impact of COVID-19 illness on metabolic phenotypes underlying type 2 diabetes mellitus: a systematic review

    Meta-analysis

  31. BMJ Open Diabetes Res Care

    Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation

    Cohort study

  32. Diabetes Obes Metab

    Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational Study

    Cohort study

  33. Lancet Diabetes Endocrinol

    Combined associations of GLP-1 receptor agonists and a healthy lifestyle with cardiovascular outcomes among individuals with type 2 diabetes: a prospective cohort study

    Cohort study

  34. Diabetes Obes Metab

    Real‐world treatment trajectories preceding GLP ‐1 receptor agonist initiation in type 2 diabetes: A descriptive UK population‐based cohort study on adherence to national clinical guidelines

    Cohort study

  35. Diabetes Obes Metab

    Sustained glucagon‐like peptide‐1 receptor agonist treatment improves glycemic control and reduces all‐cause mortality compared to dipeptidyl peptidase‐4 inhibitors: A real‐world target trial emulation in type 2 diabetes

    Cohort study

  36. Diabetologia

    Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial

    Randomized controlled trial

  37. Diabetes Res Clin Pract

    Association of remnant cholesterol with stroke risk by glycemic status: a nationwide prospective cohort study

    Cohort study

  38. Diabetes Res Clin Pract

    Impact of metformin on the risk of osteoarthritis in patients with type 2 diabetes: a real-world study

    Cohort study

  39. Cardiovasc Diabetol

    SGLT2 inhibitors reduce the salt sensitivity of blood pressure in type 2 diabetes via enhanced postprandial natriuresis

    Randomized controlled trial

  40. Diabet Med

    Characterising the impact of shift work on diet and glucose variability in healthcare employees living with type 2 diabetes: The Shift‐Diabetes study

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 721–760 of 4,758, newest first